Novo Nordisk's Board Resigns Amidst Leadership Dispute
Novo Nordisk's entire independent board is resigning following disagreements with its controlling foundation, leading to a major leadership overhaul amid ongoing struggles with market share and recent layoffs, as the company shifts its strategic focus under new CEO Mike Doustdar.